Please login to the form below

Not currently logged in
Email:
Password:

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

Moves to the Boston company from Onyx Pharmaceuticals
Intarcia Therapeutics Sunita Zalani

Boston-based biopharmaceutical firm Intarcia Therapeutics has appointed Dr Sunita Zalani as vice president, global head of regulatory affairs and quality.

She joins the company from Amgen's Onyx Pharmaceuticals subsiary, where she served as vice president of global regulatory affairs.

Dr Zalani had been with Onyx - which was acquired by Amgen last year - since 2004 and prior to that worked at Lilly as its global regulatory lead.

In her new role at Inarcia, whose most advanced prospect is a phase III version of the diabetes drug exenatide that only needs to be given once a year, Dr Zalani will sit on the leadership team and report directly to chairman, president and CEO Kurt Graves.

He said: "We led a very competitive search for the person who would best meet the steep demands of our global regulatory and quality functions, and I'm delighted Intarcia prevailed as Sunita's choice out of several other simultaneous options she had.

“Her track record shows her to be a team leader with a 'gut grasp' of how to succeed in the biotech industry.”

6th August 2014

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

We love what we do and we think it shows.It shows in the work we do, the space we work...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics